[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"clinical-pregnancy-rate\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:clinical-pregnancy-rate":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,59],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":25,"briefSummary":27,"conditions":28,"keywords":35,"overallStatus":46,"whyStopped":4,"lastUpdateSubmitDate":47,"lastUpdatePostDateStruct":48,"startDateStruct":51,"completionDateStruct":53,"leadSponsor":55,"locationsCount":58},"100528791","hyaluronan-enriched-medium-and-euploid-blastocyst-transfers-100528791",false,"NCT06165367","Hyaluronan-enriched Medium and Euploid Blastocyst Transfers","Impact of Hyaluronan-enriched Medium on Pregnancy Outcomes Following Euploid Blastocyst Transfers","GluePloid","Inclusion Criteria:\n\n* All frozen embryo transfer (FET) cycles with euploid blastocysts biopsied and vitrified on Day 5 after PGT-A.\n* Rank of randomization based on embryo quality.\n* Only hormonal replacement theraphy (HRT) cycle regimen.\n* Women aged 18 years to 46 years.\n* Having at least 1 chromosomally normal vitrified blastocyst(s) on Day 5 available for transfer.\n* All sperm samples.\n* BMI between 18 and 35.\n\nExclusion Criteria:\n\n* FET cycles with preimplantation genetic testing for monogenic disorders (PGT-M) and for structural rearrangements (PGT-SR).\n* FET cycles with mosaic \u002F aneuploid blastocysts.\n* FET cycles with unknown outcome.\n* FET cycles with Day 6 or Day 7 biopsied blastocysts.\n* FET with patients' endometrium preparation with treatments other than HRT.\n* FET where PGT-A was performed for gender selection.",true,"FEMALE","18 Years","46 Years",{"count":22,"type":23},783,"ESTIMATED","INTERVENTIONAL",[26],"NA","It has been proposed that enriching transfer media with hyaluronan (EmbryoGlue medium) improves pregnancy outcomes compared with media containing lower concentrations of this molecule. However, none of previous studies included preimplantation genetic testing for aneuploidy (PGT-A) embryos. In order to investigate the impact of this hyaluronan-enriched on pregnancy outcomes, it is essential to evaluate its efficacy on euploid-only embryo transfers. The aim of the present study is to evaluate whether a short period of exposure of euploid blastocysts to EmbryoGlue prior to and during transfer positively impact on pregnancy outcomes of frozen embryo transfer (FET) cycles.",[29,30,31,32,33,34],"Infertility","Implantation Rate","Clinical Pregnancy Rate","Live Birth Rate","Blastocysts","FET",[36,37,38,39,40,41,42,43,44,45],"HRT","PGT-A","Next-generation sequencing (NGS)","Miscarriage rate","single embryo transfer (SET)","EmbryoGlue","BMI","Embryo quality","Hyaluronan-enriched medium","Transfer medium","RECRUITING","2026-06-22",{"date":49,"type":50},"2026-06-25","ACTUAL",{"date":52,"type":50},"2024-01-15",{"date":54,"type":23},"2026-12-31",{"name":56,"class":57},"ART Fertility Clinics LLC","OTHER",1,{"id":60,"slug":61,"hasResults":11,"nctId":62,"briefTitle":63,"officialTitle":63,"acronym":64,"eligibilityCriteria":65,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":66,"enrollmentInfo":67,"targetDuration":69,"studyType":70,"phases":4,"briefSummary":71,"conditions":72,"keywords":74,"overallStatus":78,"whyStopped":4,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":58},"100613527","uterine-interstitial-myolisis-and-oocytes-retrieval-in-single-step-a-pilot-study-100613527","NCT07267754","Uterine Interstitial Myolisis and Oocytes Retrieval in Single Step: a Pilot Study","UIMandOPU","Inclusion Criteria:\n\nInfertile women with uterine fibroids who need to undergo oocytes retrieval between 18 and 45years old\n\nExclusion Criteria:\n\nFertile woman with uterine fibroids Fertile women without uterine fibroids Women under 18 years old Woman over 45 years old\n\n\\-","45 Years",{"count":68,"type":23},20,"2 Years","OBSERVATIONAL","The aim of this observational cohort study is to evaluate the pregnancy rate, the ongoing pregnancy rate and the live birth rate of infertile women aged between 18 and 45 years who undergo a single surgical step of oocyte retrieval and uterine interstitial myolisis .\n\nThe main questions of these study are:\n\n1. What is the chances of a positive pregnancy test and what is the chances of live birth for women who undergo oocyte retrieval and interstitial myolysis in a single surgical step?\n2. Are there any complications associated with performing the two surgical techniques at the same time? Researchers will calculate IVF\u002FICSI outcomes after embryotransfer of vitrified blastocystis obtained after oocyte retrieval and subsequent interstitial myolysis.\n\nWomen undergoing oocyte retrieval will agree to undergo oocyte retrieval and interstitial myolysis at the same time, to freeze their blastocysts and to transfer them into the uterus after 6 months",[73,31,32],"Pregnancy Rate IVF",[75,76,77],"Oocyte retrieval","Interstitial myolysis","Assisted Reproductive Technology","NOT_YET_RECRUITING","2025-11-25",{"date":81,"type":50},"2025-12-05",{"date":83,"type":23},"2026-01-01",{"date":85,"type":23},"2027-01-30",{"name":87,"class":57},"San Carlo Public Hospital, Potenza, Italy"]